Protect Pharmaceutical Corporation (PRTT) Fair Value & Analysis
Industrials · US · Market cap $6.3M
Protect Pharmaceutical Corporation
PRTT · US
Fair value as of: Jul 31, 2026
From 7 valuation models · updated 10 days ago
Fair value updated Jul 31, 2026, revised from $0.1114 to $0.3000 (+169.3%) since Jun 26, 2026. Share price +55.9% over the past month.
Below-average quality, and screening another 23% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case ($0.3736). The favourable scenario is already priced in.
- Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 31, 2026.
How to read this chart
60‑month range $0.0200 – $4.69 · fair‑value band $0.2132 – $0.3736 · the $0.3900 price screens above the $0.3000 fair value. Dashed = 300-day average. As of Jul 31, 2026.
Analysis
Protect Pharmaceutical Corporation (PRTT) currently trades at $0.3900, while our model-based Fair Value estimate is $0.3000, implying the stock looks roughly 23.1% overvalued today. The Quality Score stands at 43/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
The balance sheet holds a net cash position of $13.8M. Fundamentals as of Jul 31, 2026
Our scenario range runs from $0.2132 (bear case) to $0.3736 (bull case); at $0.3900, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 63% below its 52-week high, currently above its 200-day average. For context, the median of 10 Industrials peers we cover trades at -11% fair-value upside, at -23%, PRTT screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 7 models by family
Widest divergence: Asset-Based ($3.88) versus Multiples ($2.61). Highest evidence: Growth DCF (72).
Notify me when PRTT reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Quality Score breakdown
Of which business quality 45 · Market factors (momentum, volatility) 34
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties.
Full company description
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties. The company was formerly known as Pro-Tect, Inc. and changed its name to Protect Pharmaceutical Corporation in March 2010. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2025 · reported fiscal years
Protect Pharmaceutical Corporation reported revenue of $132M in FY2024 versus $5.9M in FY2020, a compound +117.2%/yr. Reported net income was −$333M in FY2025.
PRTT screens 23% overvalued. Compare with United Parcel Service, Inc →
Peer Group
Integrated Freight & Logistics · 218 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Integrated Freight & Logistics median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Integrated Freight & Logistics stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| United Parcel Service, Inc UPS | $117.72 | $104.58 | -11% |
| FedEx Corporation FDX | $314.69 | $347.68 | +10% |
| Deutsche Post AG DHL | €57.22 | €53.18 | -7% |
| DSV A/S DSV | kr 1,660 | kr 712.57 | -57% |
| Kuehne + Nagel International AG KNIN | CHF 209.90 | CHF 147.92 | -30% |
| J.B. Hunt Transport Services, Inc JBHT | $291.41 | $133.80 | -54% |
| S.F. Holding 002352 | ¥31.91 | ¥48.64 | +52% |
| C.H. Robinson Worldwide, Inc CHRW | $193.50 | $86.56 | -55% |
| Expeditors International of Washington, Inc EXPD | $172.02 | $115.95 | -33% |
| ZTO Express (Cayman) Inc 2057 | HK$181.40 | HK$241.93 | +33% |
Compare Protect Pharmaceutical Corporation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Protect Pharmaceutical Corporation (PRTT) overvalued or undervalued?
What is the fair value of PRTT?
What is the quality score of PRTT?
What is the net profit margin of PRTT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Protect Pharmaceutical Corporation and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.